BMRN vs TRV · P/E 40, rev $1.76B vs P/E 14, rev $12.15B
Biomarin Pharmaceutical Inc (BMRN) versus The Travelers Companies Inc (TRV) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
The Travelers Companies Inc (TRV) is a insurance - property & casualty company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported TRV revenue for 2026-06-30 was $12.15B. Net income was $2.21B. Revenue was up 1.9% from 2026-03-31 to 2026-06-30. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TRV currently screens at market cap $59.84B and trailing P/E 14.4.
Not investment advice. Open the BMRN and TRV stock pages for the full models.
Not investment advice.